ECRG4 and nasopharyngeal carcinoma: In vitro and in vivo functional experiments revealed that C2orf40 not only promoted the sensitivity of NPC cells to chemotherapy and radiotherapy by inducing cell cycle arrest at G2/M phase and cell apoptosis, but also inhibited the migration ability of NPC cells.